IGF1 and breast carcinoma: We extended the current evidence by providing novel findings that compared with low concentrations of circulating IGF1, high concentrations of IGF1 were independently associated with a decreased risk of all-cause mortality after breast cancer, and such association was further confirmed by a similar association between IGF1 and post-recurrence mortality.